Diabetes a obezita - Issue 40/2020

73
Editoriál

74
Spomienka na Borisa Krahulca

78
Clinical data on the use of insulin glargine 300 U/ml in adult and paediatric populations with type 1 diabetes and their meta-analysis

Peter Novodvorský

84
Metformin treatment is still under discussion

Zbynek Schroner, Vladimír Uličiansky

88
GDF15: a new predictive biomarker for type 2 diabetes mellitus in clinical practice

Andrej Dukát, Juraj Payer, Fedor Šimko

93
Impaired awareness of hypoglycaemia: management and experience from Sheffield

Peter Novodvorský, Andrei Oprescu, Jackie Elliott, Simon R Heller

99
Presence of alcohol in the breath of a diabetic patient – a possible forensic problem

Jana Gáliková

103
Does diabetes support cancer development?

Ján Murín


108
Remission of nocturnal hypoglycemia after a change in basal insulin

Daniela Kollárová

110
Biosimilar insulin glargine added to treatment with oral antidiabetics

Marek Macko

112
A basal analogue highly effective even in patients after kidney transplantation

Miroslav Paľko


114
Study EMPEROR-Reduced: design, results and implications for clinical practice

Zbynek Schroner


117
Do we need „cardio-metabolic“ specialists?

Ján Murín


119
80. virtuálna konferencia American Diabetes Association

Martin Haluzík, Zbynek Schroner

124
Rozšírenie technológií do diabetologickej praxe

Viera Doničová

125
Jubilejné XXX. diabetologické dni s medzinárodnou účasťou

Vladimír Uličiansky


Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account